CDMO/CRO Certification Program for Cell-based Assays
Program designed to qualify CRO/CDMOs to run Eurofins DiscoverX bioassays for client downstream therapeutic efforts
Cell Banking
Ensure long-term assay reproducibility with the production of bioassay cells — critical reagents for cell banks
eXpress Kits
Cell Lines & Primary Cells
cGMP Assay
Cell Culture Kits & Reagents
Recombinant Proteins & Enzymes
Membrane Preparations
Control Ligands & Inhibitors
Toolbox Products
Cytotoxicity CD16 Cells
Cytotoxicity Bioassays
Pharmacotrafficking Assays
Potency & QC Lot Testing
GPCR Internalization
Signaling Reporter Assays
Target Engagement
Targeted Protein Degradation
Checkpoint Receptors
Cytokines/Interleukins
Epigenetic Proteins
β-Arrestin Recruitment Products
cAMP Products
Calcium Products
Ion Channels
ADP Accumulation Assays
RTKs/CTKs
Nuclear Proteins
Signaling Pathway
Immuno-Oncology
Obesity/Diabetes
Assays to interrogate the MOA of GLP-1, GIP, and GCG receptors targeting therapeutics to accelerate obesity and type-2 diabetes drug development.
COVID-19 Drug Discovery
Showing 1993–2004 of 2109 results
